Pharmacological and biochemical actions of simple coumarins: Natural products with therapeutic potential

General Pharmacology: The Vascular System - Tập 27 Số 4 - Trang 713-722 - 1996
J.R.S. Hoult1,2, Miguel Payá1,2
1Fax 0171 333 4739]
2Pharmacology Group, King's College London, Manresa Road, London SW3 6LX, UK [Tel. 0171 333 4704

Tóm tắt

Từ khóa


Tài liệu tham khảo

Aporti, 1987, Effect of 8-monochloro-3-β-diethylaminoethyl-4-methyl-7 ethoxycarbonylmethoxycoumarin (AD6) on coronary circulation in the dog, Pharmacol. Res. Commun., 10, 467

Baumann, 1980, Hemmung der Prostaglandinsynthetase durch Flavonoide und Phenolderivate im Vergleich mit derem O2-Radikalfangereigenschaften, Arch. Pharm.(Weinheim), 313, 330, 10.1002/ardp.19803130409

Bertocchi, 1989, In vitro inhibition of human polymorphonuclear cell function by cloricromene, N.S. Arch. Pharmacol., 339, 697, 10.1007/BF00168664

Casley-Smith, 1986

Casley-Smith, 1992, Modern treatment of lymphoedema II. The benzopyrones, Austral. J. Dermatol., 33, 69, 10.1111/j.1440-0960.1992.tb00082.x

Casley-Smith, 1973, The electron microscopy of the effect of treatment with coumarin (Venalot) and by thoracic duct cannulation on thermal injuries, Br. J. Exp. Pathol., 54, 1

Casley-Smith, 1974, Fine structural aspects of lymphoedema in various tisues and the effect of treatment with coumarin and troxerutin, Br. J. Exp. Pathol., 55, 89

Casley-Smith, 1981, Excess plasma proteins as a cause of chronic inflammation and lymphoedema: quantitative electron microscopy, J. Pathol., 133, 69, 10.1002/path.1711330307

Casley-Smith, 1993, Reduction of filiaritic lymphoedema and elephantiasis by 5,6 benzo-α-pyrone (coumarin), and the effects of diethylcarbamazine (DEC), Ann. Trop. Med. Parasitol., 8, 247, 10.1080/00034983.1993.11812763

Casley-Smith, 1993, Treatment of lymphedema of the arms and legs with by 5,6 benzo-[α]-pyrone, N. Engl. J. Med., 329, 1158, 10.1056/NEJM199310143291604

Casley-Smith, 1974, The pathogenesis of oedemas and the therapeutic action of coumarin and related compounds, Fol. Angiolog., 3, 33

Casley-Smith, 1993, Treatment of filiarial lymphoedema and elephantiasis with 5,6 benzo-α-pyrone (coumarin), Br. Med. J., 307, 1037, 10.1136/bmj.307.6911.1037

Casley-Smith, 1976, Quantitative morphological correlations of alterations in capillary permeability, following histamine and moderate burning, in the mouse diaphragm, and the effects of benzopyrones, Microvasc. Res., 11, 279, 10.1016/0026-2862(76)90059-5

Chang, 1986, Pharmacology and Application of Chinese Materia Medica, 896

Clodius, 1982, The conservative treatment of post-mastectomy in patients with coumarin results in a marked continuous reduction in swelling, 471

Craven, 1986, Role of reactive oxygen in bile salt stimulation of colonic epithelial proliferation, J. Clin. Invest., 77, 850, 10.1172/JCI112382

Darvill, 1984, Phytoalexins and their elicitors—A defense against microbial infection in plants, Annu. Rev. Plant Physiol., 35, 243, 10.1146/annurev.pp.35.060184.001331

Das, 1986, Effects of flavonoids on induced non-enzymic lipid peroxidation, Prog. Clin. Biol. Med., 213, 243

Egan, 1990, The pharmacology, metabolism, analysis and applications of coumarin and coumarin-related compounds, Drug Metab. Rev., 22, 503, 10.3109/03602539008991449

Emerit, 1989, Free radicals and lipid peroxidation in cell pathology, Vol. 1, 177

Földi-Börcsök, 1971, Die Antiphlogistiche and Ödemhemmende Wirkung von Coumarin aus Meliotis officinalis, Arzneim.-Forsch. (Drug Res)., 21, 2025

Gresele, 1993, Cloricromene inhibits leukotriene formation by human polymorphonuclear leucocytes by suppressing arachidonate release from membrane phospholipids, Biochem. Pharmacol., 45, 123, 10.1016/0006-2952(93)90384-9

Halliwell, 1992, Free radicals, anti-oxidants and human disease: Where are we now?, J. Lab. Clin. Med., 119, 598

Harding, 1980, Isolation and identification of the antifungal compounds accumulating in the induced resistance response of carrot slices to Botrytis cinerea, Physiol. Plant Pathol., 17, 277, 10.1016/S0048-4059(80)80021-X

Hardt, 1983, Investigation of the dose-response relationship upon intraperitoneal administration of coumarin and 7-hydroxycoumarin on the carrageenan-induced edema of the rats hind paw, Arzneim.-Forsch. (Drug Res)., 33, 1662

Hazleton, 1956, Toxicity of coumarin, J. Pharmacol. Exp. Ther., 118, 348

Hoult, 1994, Inhibitory activity of a series of coumarins on leukocyte eicosanoid generation, Agents Actions, 42, 44, 10.1007/BF02014299

Huang, 1991, Vasorelaxants from Chinese herbs, emodin and scoparone, possess immunosuppressive properties, Eur. J. Pharmacol., 198, 211, 10.1016/0014-2999(91)90624-Y

Huang, 1992, Possible mechanism of immunosuppressive effect of scoparone (6,7-dimethoxycoumarin), Eur. J. Pharmacol., 217, 143, 10.1016/0014-2999(92)90835-R

Huang, 1992, Vasodilator effect of scoparone (6,7-dimethoxycoumarin) from a Chinese herb, Eur. J. Pharmacol., 218, 123, 10.1016/0014-2999(92)90155-W

Huang, 1993, Protection by scoparone against the alterations of plasma lipoproteins, vascular morphology and vascular reactivity in hyperlipidaemic diabetic rabbit, Br. J. Pharmacol., 110, 1508, 10.1111/j.1476-5381.1993.tb13993.x

Johnson, 1983, Photosensitizing toxins from plants and their biologic effects, volume 1, 345

Kendall, 1993, Effects of hydroxyethylrutosides on the permeability of microvessels in the frog mesentery, Br. J. Pharmacol., 110, 199, 10.1111/j.1476-5381.1993.tb13792.x

Kimura, 1985, Inhibition of the formation of 5-hydroxy-6,8,11,14-eicosatetraenoic acid from arachidonic acid in polymorphonuclear leukocytes by various coumarins, Biochim. Biophys. Acta, 834, 224, 10.1016/0005-2760(85)90159-6

Ko, 1989, Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens, Thromb. Haemost., 62, 996, 10.1055/s-0038-1651041

Ko, 1992, Vasorelaxation of rat thoracic aorta caused by osthole isolated from Angelica pubescens, Eur. J. Pharmacol., 219, 29, 10.1016/0014-2999(92)90576-P

Kozawa, 1981, Calcium antagonistic action of a coumarin isolated from “Qian-Hu”, a Chinese traditional medicine, J. Pharm. Pharmacol., 33, 317, 10.1111/j.2042-7158.1981.tb13789.x

Laughton, 1991, Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives, 42, 1673

Lee, 1981, Inhibition of prostaglandin biosynthesis by coumarin, 4-hydroxycoumarin and 7-hydroxycoumarin, Arzneim-Forsch (Drug Res.), 31, 640

Levine, 1970, Anticoagulants, 1445

Lindberg, 1989, Alteration of mouse cytochrome P-450coh substrate specificity by a mutation of a single amino-acid residue, Nature, 339, 632, 10.1038/339632a0

Maddi, 1992, Synthesis and anti-inflammatory activity of 3-(benzylideneamino)coumarins in rodents, J. Pharm. Sci., 81, 964, 10.1002/jps.2600810926

Mora, 1990, Structure-activity relationships of polymethoxyflavones and other flavonoids as inhibitors of non-enzymic lipid peroxidation, Biochem. Pharmacol., 40, 793, 10.1016/0006-2952(90)90317-E

Moran, 1987, Analysis of coumarin and its urinary metabolites by high-performance liquid chromatography, J. Chromatogr., 416, 165, 10.1016/0378-4347(87)80499-1

Murray, 1982

Murray, 1989, Coumarins, Nat. Prod. Rep., 8, 591, 10.1039/np9890600591

Murray, 1991, Coumarins, vol. 58, 84

Namba, 1988, Studies on cardio-active crude drugs I. Effect of coumarins on cultured myocardial cells, Planta Med., 54, 277, 10.1055/s-2006-962432

Negishi, 1989, Mouse steroid 15α-hydroxylase gene family: identification of type II P-45015α as a coumarin 7-hydroxylase, Biochemistry, 28, 4169, 10.1021/bi00436a007

Neichi, 1983, Inhibitory effect of esculetin on 5-lipoxygenase and leukotriene biosynthesis, Biochim. Biophys. Acta, 753, 130, 10.1016/0005-2760(83)90106-6

Ojewole, 1983, Mechanism of hypotensive effect of scopoletin isolated from the fruit of Tetrapleura tetraptera, Planta Med., 49, 46, 10.1055/s-2007-969809

Okuyama, 1986, Effects of oriental plant drugs on platelet aggregation II. Effect of Quian-Hu coumarins on human platelet aggregation, Planta Med., 52, 132, 10.1055/s-2007-969098

Palmgren, 1983, Aflatoxins, vol. 1, 299

Payá, 1992, Interactions of a series of coumarins with reactive oxygen species, 44, 205

Payá, 1992, Peroxyl radical scavenging by a series of coumarins, Free Rad. Res. Comms., 17, 293, 10.3109/10715769209079522

Payá, 1994, Superoxide scavenging activity in leukocytes and absence of cellular toxicity of a series of coumarins, Biochem. Pharmacol., 48, 445, 10.1016/0006-2952(94)90273-9

Piller, 1975, A comparison of the effectiveness of some anti-inflammatory drugs on thermal oedema, Br. J. Exp. Path., 56, 554

Piller, 1988, A double-blind cross-over trial of O-(β-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs, Br. J. Plast. Surg., 41, 20, 10.1016/0007-1226(88)90139-7

Porcellati, 1990, The coumarin derivative AD6 inhibits the release of arachidonic acid by interfering with phospholipase A2 activity in human platelets stimulated with thrombin, Agents Actions, 29, 364, 10.1007/BF01966469

Prosdocimi, 1985, Inhibition by AD6 (8-monochloro-3-β-diethylaminoethyl-4-methyl-7-ethoxycarbonylmethoxycoumarin) of platelet aggregation in dog stenosed artery, Thromb. Res., 39, 399, 10.1016/0049-3848(85)90163-X

Prosdocimi, 1986, Action of AD6 (8-monochloro-3-β-diethylaminoethyl-4-methyl-7-ethoxycarbonylmethoxycoumarin) on human platelets in vitro, N.S. Arch. Pharmacol., 332, 305, 10.1007/BF00504872

Ritschel, 1984, Therapeutic concentration of coumarin and predicted dosage regimens, Arzneim. Forsch. (Drug Res)., 34, 907

Ritschel, 1979, First-pass effect of coumarin in man, Int. J. Clin. Pharmacol. Biopharm., 17, 99

Sekiya, 1982, Selective inhibition of platelet lipoxygenase by esculetin, Biochim. Biophys. Acta, 713, 68, 10.1016/0005-2760(82)90167-9

Shilling, 1969, Metabolism of coumarin in man, Nature, 221, 664, 10.1038/221664b0

Superchi, 1993, Synthesis and toxicity to mammalian cells of the carrot dihydroisocoumarins, Chem. Res. Toxicol., 6, 46, 10.1021/tx00031a007

Teng, 1994, The relaxant action of osthole isolated from Angelica pubescens in guinea-pig trachea, N-S Arch. Pharmacol., 349, 202, 10.1007/BF00169838

Thastrup, 1983, Coronary vasodilatory, spasmolytic and cAMP phosphodiesterase inhibitory properties of dihydropyranocoumarins and dihydrofuranocoumarins, Acta Pharmacol. Toxicol., 52, 246, 10.1111/j.1600-0773.1983.tb01095.x

Thastrup, 1985, Inhibition of human platelet aggregation by dihydropyrano- and dihydrofuranocoumarins, a new class of cAMP phosphodiesterase inhibitors, Biochem. Pharmacol., 34, 2137, 10.1016/0006-2952(85)90407-1

Yamada, 1990, Reperfusion and readmission of oxygen, 67, 1211